Suppliers / Pisgah Laboratories

Pisgah Laboratories

United States Updated 9 July 2026

Pisgah Laboratories is an API manufacturer based in United States. It holds one active US drug master file. Its most recent recorded inspection, by US FDA, closed on 21 October 2021 as VAI.

1
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
4 of 4 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 21 October 2021 VAI US FDA
  • 8 April 2016 VAI US FDA
  • 1 August 2012 NAI US FDA
  • 8 July 2009 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Pisgah Forest, United States 3001237833

What they file, and where

Molecule Regulators Docs
Etomidate US FDA 1

Also appears on these molecule pages

Comparing suppliers?

Choose your molecules and target markets. Pisgah Laboratories comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 21 October 2021.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability